Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fluorocarbons | 5 | 2023 | 452 | 1.270 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 | 2023 | 1519 | 1.210 |
Why?
|
Prenatal Exposure Delayed Effects | 6 | 2021 | 2408 | 1.170 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 222 | 1.110 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2023 | 407 | 0.920 |
Why?
|
Environmental Pollutants | 4 | 2023 | 1179 | 0.910 |
Why?
|
Alkanesulfonic Acids | 3 | 2023 | 180 | 0.880 |
Why?
|
Leukemia, Biphenotypic, Acute | 2 | 2019 | 35 | 0.860 |
Why?
|
Leukemia | 6 | 2021 | 1511 | 0.780 |
Why?
|
Environmental Exposure | 5 | 2023 | 4234 | 0.690 |
Why?
|
Fibrosarcoma | 2 | 2020 | 348 | 0.680 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 25 | 0.620 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1179 | 0.620 |
Why?
|
Air Pollutants | 3 | 2023 | 2817 | 0.490 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1660 | 0.490 |
Why?
|
Executive Function | 3 | 2021 | 1364 | 0.480 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2023 | 1581 | 0.470 |
Why?
|
Vehicle Emissions | 2 | 2016 | 665 | 0.460 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1086 | 0.420 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1072 | 0.420 |
Why?
|
Cognition | 3 | 2018 | 6770 | 0.380 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3523 | 0.360 |
Why?
|
Sequence Analysis, RNA | 4 | 2023 | 2012 | 0.350 |
Why?
|
Child | 39 | 2023 | 77709 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 7 | 2005 | 1434 | 0.340 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3597 | 0.320 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 231 | 0.320 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3462 | 0.310 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 3 | 2022 | 294 | 0.300 |
Why?
|
Genomics | 5 | 2023 | 5720 | 0.300 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2022 | 670 | 0.290 |
Why?
|
Neoplasm, Residual | 3 | 2020 | 973 | 0.280 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1363 | 0.280 |
Why?
|
Intracellular Membranes | 3 | 2003 | 390 | 0.270 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9239 | 0.270 |
Why?
|
Child, Preschool | 22 | 2022 | 41006 | 0.250 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4262 | 0.250 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2513 | 0.250 |
Why?
|
Neoplasms | 6 | 2023 | 21683 | 0.250 |
Why?
|
Oxidative Phosphorylation | 4 | 2008 | 481 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2021 | 2649 | 0.230 |
Why?
|
Proto-Oncogene Proteins | 6 | 2021 | 4554 | 0.220 |
Why?
|
Infant | 19 | 2022 | 35136 | 0.210 |
Why?
|
Mitochondria | 7 | 2005 | 3520 | 0.210 |
Why?
|
Asparaginase | 3 | 2021 | 236 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2018 | 2942 | 0.200 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 45 | 0.200 |
Why?
|
Medical Oncology | 1 | 2013 | 2265 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 318 | 0.200 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 76 | 0.190 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 185 | 0.190 |
Why?
|
Blood Group Antigens | 1 | 2022 | 180 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2021 | 3023 | 0.180 |
Why?
|
Ikaros Transcription Factor | 2 | 2018 | 217 | 0.180 |
Why?
|
Air Pollution | 2 | 2023 | 2286 | 0.180 |
Why?
|
Pregnancy | 9 | 2023 | 29144 | 0.180 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1376 | 0.180 |
Why?
|
Mutation | 13 | 2023 | 29786 | 0.170 |
Why?
|
Tissue Banks | 2 | 2020 | 184 | 0.170 |
Why?
|
Remission Induction | 3 | 2020 | 2386 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 50 | 0.170 |
Why?
|
Fasciitis | 1 | 2019 | 65 | 0.170 |
Why?
|
Humans | 65 | 2023 | 744343 | 0.170 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 651 | 0.170 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 148 | 0.170 |
Why?
|
Myelodysplastic Syndromes | 2 | 2022 | 1352 | 0.170 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 590 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11524 | 0.160 |
Why?
|
Pyruvate Kinase | 2 | 2012 | 189 | 0.160 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 188 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2020 | 220 | 0.160 |
Why?
|
Galectins | 1 | 2021 | 268 | 0.160 |
Why?
|
Protein Isoforms | 1 | 2023 | 1730 | 0.160 |
Why?
|
Gene Duplication | 2 | 2022 | 329 | 0.160 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 155 | 0.160 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.160 |
Why?
|
Pediatrics | 1 | 2013 | 3475 | 0.160 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.150 |
Why?
|
Interleukin-3 | 6 | 2005 | 444 | 0.150 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 299 | 0.150 |
Why?
|
Polyethylene Glycols | 3 | 2021 | 1182 | 0.150 |
Why?
|
Mothers | 2 | 2018 | 2165 | 0.140 |
Why?
|
Scalp | 1 | 2019 | 380 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 449 | 0.140 |
Why?
|
Glycolysis | 7 | 2008 | 827 | 0.140 |
Why?
|
Sequence Deletion | 3 | 2018 | 1526 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2019 | 326 | 0.140 |
Why?
|
Proteins | 2 | 2010 | 6103 | 0.130 |
Why?
|
Adolescent | 18 | 2022 | 85781 | 0.130 |
Why?
|
Genetic Testing | 2 | 2019 | 3444 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 694 | 0.130 |
Why?
|
Pesticides | 1 | 2018 | 287 | 0.130 |
Why?
|
Female | 35 | 2023 | 380194 | 0.130 |
Why?
|
Apoptosis | 8 | 2005 | 9727 | 0.130 |
Why?
|
Skull | 1 | 2019 | 813 | 0.130 |
Why?
|
Gene Fusion | 1 | 2018 | 371 | 0.130 |
Why?
|
Linear Models | 4 | 2018 | 5952 | 0.130 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 1941 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 794 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
Oncogenes | 3 | 2021 | 1265 | 0.120 |
Why?
|
Male | 37 | 2022 | 350118 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 373 | 0.120 |
Why?
|
Environmental Monitoring | 2 | 2023 | 1414 | 0.120 |
Why?
|
Translocation, Genetic | 2 | 2023 | 1420 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 783 | 0.110 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 226 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2012 | 57 | 0.110 |
Why?
|
Chromosome Breakage | 1 | 2013 | 173 | 0.110 |
Why?
|
Transplants | 1 | 2015 | 209 | 0.110 |
Why?
|
Carbon | 2 | 2015 | 687 | 0.110 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 732 | 0.110 |
Why?
|
Breast Feeding | 2 | 2023 | 1338 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.110 |
Why?
|
Lymphoma, Follicular | 1 | 2016 | 435 | 0.100 |
Why?
|
Exons | 4 | 2023 | 2437 | 0.100 |
Why?
|
Fetal Blood | 1 | 2018 | 1318 | 0.100 |
Why?
|
Biopolymers | 1 | 2012 | 189 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1832 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2022 | 25625 | 0.100 |
Why?
|
Pregnancy Trimester, First | 1 | 2015 | 853 | 0.100 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 523 | 0.100 |
Why?
|
Esophageal Perforation | 1 | 2011 | 69 | 0.100 |
Why?
|
Treatment Failure | 2 | 2014 | 2618 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.090 |
Why?
|
Cell Proliferation | 5 | 2014 | 10481 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 880 | 0.090 |
Why?
|
Genes, Fungal | 2 | 2002 | 455 | 0.090 |
Why?
|
Child Behavior | 1 | 2016 | 839 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 847 | 0.090 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 169 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1671 | 0.090 |
Why?
|
Lysine | 1 | 2014 | 1007 | 0.090 |
Why?
|
Centrosome | 1 | 2010 | 201 | 0.080 |
Why?
|
Chromosome Segregation | 1 | 2010 | 235 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1526 | 0.080 |
Why?
|
Particulate Matter | 2 | 2023 | 2530 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 570 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1050 | 0.080 |
Why?
|
Young Adult | 10 | 2022 | 56430 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2050 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 4 | 2005 | 295 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 987 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8863 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.080 |
Why?
|
Intestinal Perforation | 1 | 2010 | 253 | 0.080 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3647 | 0.080 |
Why?
|
Glucose | 5 | 2004 | 4397 | 0.080 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2010 | 207 | 0.080 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.080 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 319 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11366 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1877 | 0.070 |
Why?
|
Growth Substances | 3 | 2005 | 784 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4286 | 0.070 |
Why?
|
Natural Killer T-Cells | 1 | 2010 | 316 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2849 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.070 |
Why?
|
Granulocytes | 1 | 2008 | 548 | 0.070 |
Why?
|
Mice | 19 | 2023 | 81183 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 4803 | 0.070 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2020 | 841 | 0.070 |
Why?
|
Stem Cells | 3 | 2010 | 3567 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2948 | 0.060 |
Why?
|
Adult | 11 | 2022 | 214055 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3505 | 0.060 |
Why?
|
Prognosis | 6 | 2021 | 29063 | 0.060 |
Why?
|
Molecular Targeted Therapy | 3 | 2022 | 2727 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5853 | 0.060 |
Why?
|
Child Development | 1 | 2016 | 2223 | 0.060 |
Why?
|
Syndrome | 1 | 2010 | 3251 | 0.060 |
Why?
|
Environmental Policy | 1 | 2023 | 33 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2951 | 0.060 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2003 | 24 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12208 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2016 | 2085 | 0.060 |
Why?
|
Animals | 22 | 2023 | 168757 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 142 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2599 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1878 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13695 | 0.060 |
Why?
|
Escherichia coli | 1 | 2015 | 4217 | 0.060 |
Why?
|
MicroRNAs | 2 | 2010 | 3752 | 0.060 |
Why?
|
Climate | 1 | 2023 | 147 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 40561 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39050 | 0.050 |
Why?
|
Cytochromes c | 1 | 2003 | 180 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2023 | 118 | 0.050 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10180 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2008 | 1117 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1880 | 0.050 |
Why?
|
Signal Transduction | 4 | 2018 | 23403 | 0.050 |
Why?
|
Alleles | 3 | 2022 | 6933 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8663 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4149 | 0.050 |
Why?
|
Oxygen Consumption | 3 | 2008 | 1869 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 379 | 0.050 |
Why?
|
Nitrogen Dioxide | 1 | 2023 | 490 | 0.050 |
Why?
|
United States | 5 | 2023 | 69872 | 0.050 |
Why?
|
Research Design | 2 | 2016 | 5987 | 0.050 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2000 | 16 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4665 | 0.050 |
Why?
|
Lactation | 1 | 2023 | 412 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3507 | 0.050 |
Why?
|
Survival Analysis | 3 | 2019 | 10252 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2752 | 0.050 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 434 | 0.050 |
Why?
|
Porins | 1 | 2000 | 81 | 0.050 |
Why?
|
Oncogene Fusion | 1 | 2020 | 99 | 0.040 |
Why?
|
Cytosol | 1 | 2003 | 901 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8340 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.040 |
Why?
|
Codon | 1 | 2021 | 611 | 0.040 |
Why?
|
Electron Transport | 1 | 2000 | 211 | 0.040 |
Why?
|
Age Factors | 4 | 2018 | 18370 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 2000 | 385 | 0.040 |
Why?
|
Prospective Studies | 3 | 2022 | 53288 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 342 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 743 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2019 | 328 | 0.040 |
Why?
|
DNA Primers | 2 | 2014 | 2892 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 9959 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2019 | 486 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2004 | 1904 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7913 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4462 | 0.040 |
Why?
|
Autophagy | 1 | 2005 | 1300 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.040 |
Why?
|
Agriculture | 1 | 2018 | 190 | 0.040 |
Why?
|
Survival Rate | 2 | 2021 | 12788 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6895 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 618 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1723 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6538 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2617 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1660 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1039 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 496 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 246 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 781 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 892 | 0.030 |
Why?
|
Biological Transport | 1 | 2000 | 2118 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 497 | 0.030 |
Why?
|
Sulfonic Acids | 1 | 2015 | 96 | 0.030 |
Why?
|
Cell Survival | 3 | 2001 | 5882 | 0.030 |
Why?
|
bcl-X Protein | 3 | 2002 | 411 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2000 | 914 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 375 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1157 | 0.030 |
Why?
|
Caprylates | 1 | 2015 | 111 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13284 | 0.030 |
Why?
|
Cell Division | 4 | 2004 | 4568 | 0.030 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1060 | 0.030 |
Why?
|
Aerobiosis | 2 | 2004 | 106 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 367 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 426 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2015 | 552 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1588 | 0.030 |
Why?
|
California | 1 | 2018 | 1402 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9313 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 230 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 755 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 380 | 0.030 |
Why?
|
Ethanol | 1 | 2000 | 1342 | 0.030 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.030 |
Why?
|
Pyruvic Acid | 2 | 2008 | 200 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1574 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1677 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6314 | 0.030 |
Why?
|
Phenotype | 4 | 2016 | 16365 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12959 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1484 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15295 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1252 | 0.030 |
Why?
|
Maternal Age | 1 | 2015 | 802 | 0.030 |
Why?
|
Parity | 1 | 2015 | 929 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3588 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2749 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 21827 | 0.020 |
Why?
|
Doxorubicin | 1 | 2018 | 2234 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16689 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2429 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1106 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 2 | 2002 | 192 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3772 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 72290 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5078 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12797 | 0.020 |
Why?
|
Protein Kinases | 1 | 2018 | 1640 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 494 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5686 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6622 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2065 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20822 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3305 | 0.020 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2002 | 440 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2011 | 390 | 0.020 |
Why?
|
Adenosine Diphosphate | 2 | 2002 | 425 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.020 |
Why?
|
Skin Diseases, Bacterial | 1 | 2010 | 66 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2010 | 354 | 0.020 |
Why?
|
Social Behavior | 1 | 2016 | 1127 | 0.020 |
Why?
|
Neurons | 2 | 2010 | 9338 | 0.020 |
Why?
|
Glioblastoma | 1 | 2004 | 3481 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2109 | 0.020 |
Why?
|
Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 277 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
Myogenic Regulatory Factors | 1 | 2008 | 106 | 0.020 |
Why?
|
Cell Line | 4 | 2003 | 15997 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 2010 | 246 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1538 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2014 | 19229 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1866 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7880 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 2994 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2008 | 14557 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9648 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5172 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1799 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9734 | 0.020 |
Why?
|
Microcephaly | 1 | 2010 | 432 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2765 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 63114 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2488 | 0.020 |
Why?
|
Mitosis | 1 | 2010 | 1208 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2010 | 1041 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2005 | 242 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2004 | 2503 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 77449 | 0.020 |
Why?
|
Cycloheximide | 1 | 2004 | 347 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2661 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.010 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2003 | 75 | 0.010 |
Why?
|
Rotenone | 1 | 2003 | 43 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3064 | 0.010 |
Why?
|
Neurogenesis | 1 | 2010 | 838 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3703 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2004 | 2938 | 0.010 |
Why?
|
Succinates | 1 | 2003 | 83 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2000 | 2025 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 712 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2004 | 898 | 0.010 |
Why?
|
Cell Respiration | 1 | 2003 | 201 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2003 | 146 | 0.010 |
Why?
|
Lactic Acid | 1 | 2008 | 1133 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7149 | 0.010 |
Why?
|
Fermentation | 1 | 2002 | 144 | 0.010 |
Why?
|
Binding Sites | 2 | 2002 | 6114 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6386 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2003 | 5974 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3689 | 0.010 |
Why?
|
RNA, Viral | 1 | 2010 | 2902 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18111 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 927 | 0.010 |
Why?
|
Anemia | 1 | 2010 | 1506 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5442 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2000 | 2540 | 0.010 |
Why?
|
Cells | 1 | 2001 | 168 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2002 | 689 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9438 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 1137 | 0.010 |
Why?
|
Lysosomes | 1 | 2005 | 893 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2645 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1856 | 0.010 |
Why?
|
S Phase | 1 | 2000 | 423 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21746 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2002 | 1246 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11483 | 0.010 |
Why?
|
Interphase | 1 | 1999 | 226 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 643 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3701 | 0.010 |
Why?
|
Dimerization | 1 | 1999 | 893 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2002 | 742 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15519 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1379 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2000 | 560 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11031 | 0.010 |
Why?
|
Cerebellum | 1 | 2003 | 1488 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2206 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5892 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1583 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6234 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3719 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7474 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 13033 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 12804 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3282 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1888 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3846 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8428 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4386 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18029 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5524 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3340 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2000 | 2421 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 4409 | 0.010 |
Why?
|
Lung | 1 | 2008 | 9856 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2000 | 2899 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20129 | 0.000 |
Why?
|
Inflammation | 1 | 2008 | 10638 | 0.000 |
Why?
|
Gene Expression | 1 | 2000 | 7799 | 0.000 |
Why?
|
Protein Binding | 1 | 1999 | 9386 | 0.000 |
Why?
|
Cytokines | 1 | 1999 | 7322 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13102 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9583 | 0.000 |
Why?
|